Abstract:Blood compatibility is a long sought-after goal in biomaterials research, but remains an elusive one, and in spite of extensive work in this area, there is still no definitive information on the relationship between material properties and blood responses such as coagulation and thrombus formation. Materials modified with heparin-mimicking polymers have shown promise and indeed may be seen as comparable to materials modified with heparin itself. In this work, heparin was conceptualized as consisting of two major structural elements: saccharide- and sulfonate-containing units, and polymers based on this concept were developed. Copolymers of 2-methacrylamido glucopyranose, containing saccharide groups, and sodium 4-vinylbenzenesulfonate, containing sulfonate groups, were graft-polymerized on vinyl-functionalized polyurethane (PU) surfaces by free radical polymerization. This graft polymerization method is simple, and the saccharide and sulfonate contents are tunable by regulating the feed ratio of the monomers. Homopolymer-grafted materials, containing only sulfonate or saccharide groups, showed different effects on cell-surface interactions including platelet adhesion, adhesion and proliferation of vascular endothelial cells, and adhesion and proliferation of smooth muscle cells. The copolymer-grafted materials showed effects due to both sulfonate and saccharide elements with respect to blood responses, and the optimum composition was obtained at a 2:1 ratio of sulfonate to saccharide units (material designated as PU-PS1M1). In cell adhesion experiments, this material showed the lowest platelet and human umbilical vein smooth muscle cell density and the highest human umbilical vein endothelial cell density. Among the materials investigated, PU-PS1M1 also had the longest plasma clotting time. This material was thus shown to be multifunctional with a combination of properties, suggesting thromboresistant behavior in blood contact.

Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues

An Efficient Anticoagulant Candidate: Characterization, Synthesis and in Vivo Study of a Fondaparinux Analogue Rrt1.17.

Total Synthesis of Anticoagulant Pentasaccharide Fondaparinux.

Design and Synthesis of Neutralizable Fondaparinux.

Synthesis of Anticoagulant Pentasaccharide Fondaparinux via 3,5-Dimethyl-4-(2'-phenylethynylphenyl)phenyl Glycosides

Formal Synthesis of Anticoagulant Drug Fondaparinux Sodium.

Catalytic Effects of Different Heparin Analogs on the Hydrolysis of Auramine O.

beta-Stereoselectivity of Glucuronic Acid Analogues Mediated by 2-Cyanobenzyl Group

Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A/ORG 31540)

Pharmacological Effects And Clinical Applications Of Ultra Low Molecular Weight Heparins

Preactivation-based, Iterative One-Pot Synthesis of Anticoagulant Pentasaccharide Fondaparinux Sodium

A heparin derivatives library constructed by chemical modification and enzymatic depolymerization for exploitation of non-anticoagulant functions

Selective Inhibition of PAR4 (Protease-Activated Receptor 4)-Mediated Platelet Activation by a Synthetic Nonanticoagulant Heparin Analog

Hydrolysis of Heparinase Ⅰ to SyntheticHeparin-Pentasaccharide and Effecton Its Anti-factor Xa Activity

Sulfonate Groups and Saccharides As Essential Structural Elements in Heparin-Mimicking Polymers Used As Surface Modifiers: Optimization of Relative Contents for Antithrombogenic Properties.

Combinatorial One-Pot Chemoenzymatic Synthesis of Heparin.

Heparosan-derived heparan sulfate/heparin-like compounds: one kind of potential therapeutic agents.

Fondaparinux and Direct Oral Anticoagulants

Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin

Preparation and structural characterization of a sulfated octasaccharide with heparin-like anticoagulant activity

Synthesis and Biological Profiling of Seven Heparin and Heparan Sulphate Analogue Trisaccharides